CLINICAL_TRIALS
trial_result
· 2017-08-15
Clinical Trial Update: A Study in Moderate to Severe Rheumatoid Arthritis [Phase 3]
Summary
A Phase 3 clinical trial in moderate to severe rheumatoid arthritis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-08-15